Significance of TLR4/MyD88 expression in breast cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 7034-7039

  Chen, Xiangjin ^a   Zhao, Feng ^a   Zhang, Huihao ^a   Zhu, Youzhi ^a   Wu, Kunlin ^a   Tan, Guozheng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MyD88; TLR4

Indexed keywords

MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; TUMOR MARKER;

ADULT; AGED; BREAST NEOPLASMS; CANCER STAGING; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RISK FACTOR; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; TUMOR VOLUME; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TREATMENT OUTCOME; TUMOR BURDEN; UP-REGULATION;

EID: 84938582182     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 2010; 102: 908-915.
3. Wang AC, Su QB, Wu FX, Zhang XL, Liu PS. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur J Clin Invest 2009; 39: 157-164.
4. Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 2009; 46: 2876-2884.
5. Egunsola AT, Zawislak CL, Akuffo AA, Chalmers SA, Ewer JC, Vail CM, Lombardo JC, Perez DN, Kurt RA. Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. Cell Immunol 2012; 272: 220-229.
6. Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 2010; 29: 92.
7. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
8. Breast cancer diagnostic and treatment practices (2011 edition). Chinese Journal of Practical Surgery 2011; 10: 902-907.
9. Jun LB, Zhang HY, W XH. TLR4 protein expression in breast cancer tissue and its relationship with apoptosis and proliferation. General Surgery (Electronic Version) 2011; 05: 211-213.
10. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.
11. Ehsan N, Murad S, Ashiq T, Mansoor MU, Gul S, Khalid S, Younas M. Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast. Tumour Biol 2013; 34: 1053-1059.
12. Petricevic B, Vrbanec D, Jakic-Razumovic J, Brcic I, Rabic D, Badovinac T, Ozimec E, Bali V. Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Med Oncol 2012; 29: 486-494.